Effect	effect	O	O	O	O
of	of	O	O	O	O
converting	converting	O	O	O	O
enzyme	enzyme	O	O	O	O
inhibition	inhibition	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
course	course	O	O	O	O
of	of	O	O	O	O
adriamycin-induced	adriamycin-induced	O	O	O	O
nephropathy	nephropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
converting	converting	O	O	O	O
enzyme	enzyme	O	O	O	O
inhibitor	inhibitor	O	O	O	O
(	(	O	O	O	O
CEI	cei	O	O	O	O
)	)	O	O	O	O
enalapril	enalapril	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
assessed	assessed	O	O	O	O
in	in	O	O	O	O
Munich-Wistar	munich-wistar	O	O	O	O
rats	rats	O	O	O	O
with	with	O	O	O	O
established	established	O	O	O	O
adriamycin	adriamycin	CHEMICALS	O	OTHERS	I
nephrosis	nephrosis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Rats	rats	O	O	O	O
were	were	O	O	O	O
given	given	O	O	O	O
a	a	O	O	O	O
single	single	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
adriamycin	adriamycin	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
one	one	O	O	O	O
month	month	O	O	O	O
later	later	O	O	O	O
divided	divided	O	O	O	O
into	into	O	O	O	O
four	four	O	O	O	O
groups	groups	O	O	O	O
matched	matched	O	O	O	O
for	for	O	O	O	O
albuminuria	albuminuria	O	DISEASE	OTHERS	I
,	,	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
plasma	plasma	O	O	O	O
albumin	albumin	O	O	O	O
concentration	concentration	O	O	O	O
.	.	O	O	O	O

Groups	groups	O	O	O	O
1	1	O	O	O	O
and	and	O	O	O	O
3	3	O	O	O	O
remained	remained	O	O	O	O
untreated	untreated	O	O	O	O
while	while	O	O	O	O
groups	groups	O	O	O	O
2	2	O	O	O	O
and	and	O	O	O	O
4	4	O	O	O	O
received	received	O	O	O	O
enalapril	enalapril	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Groups	groups	O	O	O	O
1	1	O	O	O	O
and	and	O	O	O	O
2	2	O	O	O	O
underwent	underwent	O	O	O	O
micropuncture	micropuncture	O	O	O	O
studies	studies	O	O	O	O
after	after	O	O	O	O
10	10	O	O	O	O
days	days	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
short-term	short-term	O	O	O	O
studies	studies	O	O	O	O
showed	showed	O	O	O	O
that	that	O	O	O	O
enalapril	enalapril	CHEMICALS	O	OTHERS	I
reduced	reduced	O	O	O	O
arterial	arterial	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
(	(	O	O	O	O
101	101	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
2	2	O	O	O	O
vs.	vs.	O	O	O	O
124	124	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
3	3	O	O	O	O
mm	mm	O	O	OTHERS	I
Hg	hg	O	O	OTHERS	I
,	,	O	O	O	O
group	group	O	O	O	O
2	2	O	O	O	O
vs.	vs.	O	O	O	O
1	1	O	O	O	O
,	,	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
glomerular	glomerular	O	O	O	O
capillary	capillary	O	O	O	O
pressure	pressure	O	O	O	O
(	(	O	O	O	O
54	54	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
1	1	O	O	O	O
vs.	vs.	O	O	O	O
61	61	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
2	2	O	O	O	O
mm	mm	O	O	OTHERS	I
Hg	hg	O	O	OTHERS	I
,	,	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
without	without	O	O	O	O
reducing	reducing	O	O	O	O
albuminuria	albuminuria	O	DISEASE	OTHERS	I
(	(	O	O	O	O
617	617	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
50	50	O	O	O	O
vs.	vs.	O	O	O	O
570	570	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
47	47	O	O	O	O
mg/day	mg/day	O	O	O	O
)	)	O	O	O	O
or	or	O	O	O	O
GFR	gfr	O	O	O	O
(	(	O	O	O	O
1.03	1.03	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
0.04	0.04	O	O	O	O
vs.	vs.	O	O	O	O
1.04	1.04	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
0.11	0.11	O	O	O	O
ml/min	ml/min	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Groups	groups	O	O	O	O
3	3	O	O	O	O
and	and	O	O	O	O
4	4	O	O	O	O
were	were	O	O	O	O
studied	studied	O	O	O	O
at	at	O	O	O	O
four	four	O	O	O	O
and	and	O	O	O	O
at	at	O	O	O	O
six	six	O	O	O	O
months	months	O	O	O	O
to	to	O	O	O	O
assess	assess	O	O	O	O
the	the	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
enalapril	enalapril	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
progression	progression	O	O	O	O
of	of	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
in	in	O	O	O	O
adriamycin	adriamycin	CHEMICALS	O	OTHERS	I
nephrosis	nephrosis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Chronic	chronic	O	O	O	O
enalapril	enalapril	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
reduced	reduced	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
without	without	O	O	O	O
reducing	reducing	O	O	O	O
albuminuria	albuminuria	O	DISEASE	OTHERS	I
in	in	O	O	O	O
group	group	O	O	O	O
4	4	O	O	O	O
.	.	O	O	O	O

Untreated	untreated	O	O	O	O
group	group	O	O	O	O
3	3	O	O	O	O
rats	rats	O	O	O	O
exhibited	exhibited	O	O	O	O
a	a	O	O	O	O
progressive	progressive	O	O	O	O
reduction	reduction	O	O	O	O
in	in	O	O	O	O
GFR	gfr	O	O	O	O
(	(	O	O	O	O
0.35	0.35	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
0.08	0.08	O	O	O	O
ml/min	ml/min	O	O	O	O
at	at	O	O	O	O
4	4	O	O	O	O
months	months	O	O	O	O
,	,	O	O	O	O
0.27	0.27	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
0.07	0.07	O	O	O	O
ml/min	ml/min	O	O	O	O
at	at	O	O	O	O
6	6	O	O	O	O
months	months	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Enalapril	enalapril	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
blunted	blunted	O	O	O	O
but	but	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
prevent	prevent	O	O	O	O
reduction	reduction	O	O	O	O
in	in	O	O	O	O
GFR	gfr	O	O	O	O
in	in	O	O	O	O
group	group	O	O	O	O
4	4	O	O	O	O
(	(	O	O	O	O
0.86	0.86	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
0.15	0.15	O	O	O	O
ml/min	ml/min	O	O	O	O
at	at	O	O	O	O
4	4	O	O	O	O
months	months	O	O	O	O
,	,	O	O	O	O
0.69	0.69	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
0.13	0.13	O	O	O	O
ml/min	ml/min	O	O	O	O
at	at	O	O	O	O
6	6	O	O	O	O
months	months	O	O	O	O
,	,	O	O	O	O
both	both	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
0.05	0.05	O	O	O	O
vs.	vs.	O	O	O	O
group	group	O	O	O	O
3	3	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Reduction	reduction	O	O	O	O
in	in	O	O	O	O
GFR	gfr	O	O	O	O
was	was	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
development	development	O	O	O	O
of	of	O	O	O	O
glomerular	glomerular	O	DISEASE	OTHERS	I
sclerosis	sclerosis	O	DISEASE	OTHERS	I
in	in	O	O	O	O
both	both	O	O	O	O
treated	treated	O	O	O	O
and	and	O	O	O	O
untreated	untreated	O	O	O	O
rats.(ABSTRACT	rats.(abstract	O	O	O	O
TRUNCATED	truncated	O	O	O	O
AT	at	O	O	O	O
250	250	O	O	O	O
WORDS	words	O	O	O	O
)	)	O	O	O	O

